To Be Discontinued Rheumatology
Adalimumab-ryvk Kit · 302 days since initial FDA posting
Brand: SIMLANDI
FDA lists Adalimumab-ryvk Kit as To Be Discontinued (Teva Pharmaceuticals USA, Inc.).
No availability text on this FDA row.
Adalimumab-ryvk Kit: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Adalimumab-ryvk Kit
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Presentation
- Simlandi, Kit, Kit (NDC 51759-523-21)
- Package NDC
- 51759-523-21
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Nov 13, 2025
- Last Updated
- Nov 13, 2025
- Therapeutic Category
- Rheumatology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.